U.S. federal trademark · Serial No. 76272229 · Reg. No. 2730132
pharmaceutical preparations for hormone replacement therapies, namely cancer gene therapy, diabetes therapy, T-Cell therapy, blood growth factors, neural growth factor therapy, anti-coagulant therapy, biological response modifier therapy, anti-cancer antibody therapy, anti-viral therapy, anti-microbial therapy; drug screening reagents, namely cytokine receptor assay reagents; and high throughput assays
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.